- Sector: Healthcare
- Industry: Biotechnology
- Full Time Employees: 208
- http://www.editasmedicine.com
- Founded in 2013
- Headquartered in Cambridge, Massachusetts.
Friday, March 11, 2016
Editas Medicine (EDIT) began trading on the Nasdaq on 3 Feb 2016
Editas Medicine is a clinical stage genome editing company. The company is a leader in the nascent field of direct gene editing using CRISPR/Cas9 which has the potential to cure many inherited diseases.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment